论文信息 - Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections - 字舞流文

Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections

J. Epstein | S. Wendel | D. Somuah | T. Burnouf | W. Martin Smid

[1] M. A. Mostajo-Radji,et al. Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic , 2020, npj Vaccines.

[2] D. Devine,et al. Guidance for the procurement of COVID‐19 convalescent plasma: differences between high‐ and low‐middle‐income countries , 2020, Vox sanguinis.

[3] J. Epstein,et al. Use of COVID‐19 convalescent plasma in low‐ and middle‐income countries: a call for ethical principles and the assurance of quality and safety , 2020, Vox sanguinis.

[4] J. Epstein,et al. Points to consider in the preparation and transfusion of COVID‐19 convalescent plasma , 2020, Vox sanguinis.

[5] John L. Perez,et al. Selection of diverse strains to assess broad coverage of the bivalent FHbp meningococcal B vaccine , 2020, npj Vaccines.

[6] J. Allain,et al. Ebola: a call for blood transfusion strategy in sub-Saharan Africa , 2014, The Lancet.